• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

选择性非甾体抗炎药与非选择性非甾体抗炎药预防髋关节置换术后异位骨化的比较:一项荟萃分析。

Selective versus non-selective NSAIDs as prophylaxis for heterotopic ossification following hip arthroplasty: a meta-analysis.

机构信息

Department of Orthopaedic, Trauma, and Reconstructive Surgery, RWTH University Hospital, Pauwelsstraße 30, 52074, Aachen, Germany.

Department of Medicine, Surgery and Dentistry, University of Salerno, 84081, Baronissi, SA, Italy.

出版信息

J Orthop Traumatol. 2022 Jul 9;23(1):30. doi: 10.1186/s10195-022-00646-7.

DOI:10.1186/s10195-022-00646-7
PMID:35809109
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9271145/
Abstract

BACKGROUND

Some patients have demonstrated evidence of heterotopic ossification (HO) following total hip arthroplasty (THA). Selective and non-selective non-steroidal anti-inflammatory drugs (NSAIDs) are used as prophylaxis for HO following THA. This meta-analysis compared selective versus non-selective NSAIDs as prophylaxis for HO following THA.

MATERIAL AND METHODS

The present study was conducted according to the PRISMA 2020 guidelines. All the clinical investigations comparing selective versus non-selective NSAIDs as prophylaxis for HO following THA were accessed in February 2022. An assessment of the methodological quality and statistical analyses were performed through the risk of bias summary tool of the Review Manager 5.3 software (Cochrane Collaboration, Copenhagen). The modified Brooker staging system was used to rate the efficacies of the interventions.

RESULTS

Data from 8 studies and 1526 patients were collected. 60.8% were female. No difference was found in the sample size, mean age, and percentage of females between the two groups at baseline. No statistically significant difference was found between selective and non-selective NSAIDs in term of efficacy. 72% (1078 of 1502) of the patients were classified as Brooker 0, 21% (322 of 1502) as Brooker I, 5% (80 of 1502) as Brooker II, 1% (16 of 1502) as Brooker III, and 0.1% (2 of 1502) as Brooker IV.

CONCLUSION

Selective and non-selective NSAIDs were equally effective when used as prophylaxis for HO following THA.

LEVEL OF EVIDENCE

Level III, systematic review and meta-analysis.

摘要

背景

一些患者在全髋关节置换术后(THA)出现了异位骨化(HO)的证据。选择性和非选择性非甾体抗炎药(NSAIDs)被用于预防 THA 后 HO 的发生。本荟萃分析比较了选择性与非选择性 NSAIDs 作为 THA 后 HO 预防的效果。

材料和方法

本研究根据 PRISMA 2020 指南进行。所有比较选择性与非选择性 NSAIDs 作为 THA 后 HO 预防的临床研究均于 2022 年 2 月进行检索。通过 Review Manager 5.3 软件(Cochrane 协作,哥本哈根)的风险偏倚摘要工具对方法学质量和统计分析进行评估。改良的布鲁克分期系统用于评估干预措施的疗效。

结果

共纳入 8 项研究和 1526 例患者的数据。女性占 60.8%。两组患者在基线时的样本量、平均年龄和女性比例均无差异。选择性和非选择性 NSAIDs 在疗效方面无统计学差异。72%(1078/1502)的患者为布鲁克 0 期,21%(322/1502)为布鲁克 I 期,5%(80/1502)为布鲁克 II 期,1%(16/1502)为布鲁克 III 期,0.1%(2/1502)为布鲁克 IV 期。

结论

选择性和非选择性 NSAIDs 作为 THA 后 HO 的预防措施同样有效。

证据水平

III 级,系统评价和荟萃分析。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c2/9271145/77ebdcbe7f76/10195_2022_646_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c2/9271145/dbe31d094806/10195_2022_646_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c2/9271145/4a73d73d3148/10195_2022_646_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c2/9271145/8dfe8d7d1a83/10195_2022_646_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c2/9271145/77ebdcbe7f76/10195_2022_646_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c2/9271145/dbe31d094806/10195_2022_646_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c2/9271145/4a73d73d3148/10195_2022_646_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c2/9271145/8dfe8d7d1a83/10195_2022_646_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c2/9271145/77ebdcbe7f76/10195_2022_646_Fig4_HTML.jpg

相似文献

1
Selective versus non-selective NSAIDs as prophylaxis for heterotopic ossification following hip arthroplasty: a meta-analysis.选择性非甾体抗炎药与非选择性非甾体抗炎药预防髋关节置换术后异位骨化的比较:一项荟萃分析。
J Orthop Traumatol. 2022 Jul 9;23(1):30. doi: 10.1186/s10195-022-00646-7.
2
NSAIDs for Prophylaxis for Heterotopic Ossification After Total Hip Arthroplasty: A Bayesian Network Meta-analysis.非甾体抗炎药用于全髋关节置换术后异位骨化的预防:一项贝叶斯网络荟萃分析。
Calcif Tissue Int. 2021 Feb;108(2):196-206. doi: 10.1007/s00223-020-00763-7. Epub 2020 Oct 12.
3
Selective COX-2 inhibitor versus non-selective COX-2 inhibitor for the prevention of heterotopic ossification after total hip arthroplasty: A meta-analysis.选择性环氧化酶-2抑制剂与非选择性环氧化酶-2抑制剂预防全髋关节置换术后异位骨化的Meta分析
Medicine (Baltimore). 2018 Aug;97(31):e11649. doi: 10.1097/MD.0000000000011649.
4
Efficacy of ibuprofen and indomethacin as prophylaxis of heterotopic ossification: a comparative study.布洛芬和吲哚美辛预防异位骨化的疗效:一项比较研究。
Sci Rep. 2023 Nov 18;13(1):20210. doi: 10.1038/s41598-023-47508-8.
5
Non-steroidal anti-inflammatory drugs for heterotopic ossification prophylaxis after total hip arthroplasty: a systematic review and meta-analysis.非甾体抗炎药预防全髋关节置换术后异位骨化:系统评价和荟萃分析。
Bone Joint J. 2018 Jul;100-B(7):915-922. doi: 10.1302/0301-620X.100B7.BJJ-2017-1467.R1.
6
Efficacy of NSAIDs versus radiotherapy for heterotopic ossification prophylaxis following total hip arthroplasty in high-risk patients: a systematic review and meta-analysis.非甾体抗炎药与放疗在预防高危患者全髋关节置换术后异位骨化的疗效比较:系统评价和荟萃分析。
Hip Int. 2022 Sep;32(5):576-590. doi: 10.1177/1120700021991115. Epub 2021 Mar 18.
7
Nonsteroidal Anti-inflammatory Drugs as Prophylaxis for Heterotopic Ossification after Total Hip Arthroplasty: A Systematic Review and Meta-Analysis.非甾体类抗炎药用于全髋关节置换术后异位骨化的预防:一项系统评价和荟萃分析
Medicine (Baltimore). 2015 May;94(18):e828. doi: 10.1097/MD.0000000000000828.
8
Optimal strategies for the prevention of heterotopic ossification after total hip arthroplasty: A network meta-analysis.全髋关节置换术后预防异位骨化的最佳策略:网络荟萃分析。
Int J Surg. 2019 Feb;62:74-85. doi: 10.1016/j.ijsu.2018.12.011. Epub 2019 Jan 4.
9
Diclofenac for prophylaxis of heterotopic ossification after hip arthroplasty: a systematic review.双氯芬酸预防髋关节置换术后异位骨化:系统评价。
Hip Int. 2022 Mar;32(2):144-151. doi: 10.1177/1120700020978194. Epub 2020 Dec 3.
10
[Selective COX-2 inhibitor versus nonselective COX-1 and COX-2 inhibitor in the prevention of heterotopic ossification after total hip arthroplasty: a meta-analysis of randomised trials].[选择性环氧化酶-2抑制剂与非选择性环氧化酶-1和环氧化酶-2抑制剂在全髋关节置换术后预防异位骨化中的比较:随机试验的荟萃分析]
Zhongguo Gu Shang. 2014 Jul;27(7):609-14.

引用本文的文献

1
Long-term clinical comparison of three different femoral stems in Total Hip Arthroplasty with femoral shortening in patients with high-riding hips.三种不同股骨柄在高位髋关节全髋关节置换术中伴股骨缩短的长期临床比较
J Orthop Surg Res. 2025 May 17;20(1):479. doi: 10.1186/s13018-025-05889-8.
2
Standardized protocol during acetabular fracture surgery results in low rates of heterotopic ossification.髋臼骨折手术中的标准化方案导致异位骨化发生率较低。
Eur J Orthop Surg Traumatol. 2024 Dec 24;35(1):47. doi: 10.1007/s00590-024-04144-w.
3
Subsidence of the Corail stem in total hip arthroplasty: no influence of bony contact.

本文引用的文献

1
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
2
Heterotopic ossification in primary total hip arthroplasty using the posterolateral compared to the direct lateral approach.初次全髋关节置换术中应用后外侧入路与直接外侧入路的异位骨化比较。
Arch Orthop Trauma Surg. 2021 Jul;141(7):1253-1259. doi: 10.1007/s00402-021-03783-6. Epub 2021 Feb 3.
3
Heterotopic ossification after total hip arthroplasty: radiological comparison between a direct anterior approach without an orthopaedic table and a posterior approach.
全髋关节置换术后 Corail 柄下沉:与骨接触无关。
J Orthop Traumatol. 2024 Nov 10;25(1):53. doi: 10.1186/s10195-024-00794-y.
4
Effectiveness of indomethacin in preventing Heterotopic Ossification: a systematic review and meta-analysis of randomized controlled trials.吲哚美辛预防异位骨化的有效性:随机对照试验的系统评价和荟萃分析。
J Orthop Surg Res. 2024 Sep 28;19(1):589. doi: 10.1186/s13018-024-05086-z.
5
Prevention of heterotopic ossification in primary total hip arthroplasty: a bone in the dark.初次全髋关节置换术中异位骨化的预防:一项未知领域的研究。
Eur J Orthop Surg Traumatol. 2024 Dec;34(8):3805-3807. doi: 10.1007/s00590-024-04087-2. Epub 2024 Sep 23.
6
"Heterotopic ossification after total hip arthroplasty through direct anterior approach without a dedicated orthopaedic table or direct lateral approach: a quasi-randomized single-center study".直接前入路或直接外侧入路行全髋关节置换术后异位骨化:一项准随机单中心研究
Arch Orthop Trauma Surg. 2024 Sep;144(9):4225-4232. doi: 10.1007/s00402-024-05510-3. Epub 2024 Sep 23.
7
Efficacy of ibuprofen and indomethacin as prophylaxis of heterotopic ossification: a comparative study.布洛芬和吲哚美辛预防异位骨化的疗效:一项比较研究。
Sci Rep. 2023 Nov 18;13(1):20210. doi: 10.1038/s41598-023-47508-8.
8
Tourniquet use following blast-associated complex lower limb injury and traumatic amputation promotes end organ dysfunction and amplified heterotopic ossification formation.止血带在爆炸相关的复杂下肢损伤和创伤性截肢中的应用会导致终末器官功能障碍和异位骨化形成加剧。
J Orthop Surg Res. 2022 Sep 19;17(1):422. doi: 10.1186/s13018-022-03321-z.
全髋关节置换术后异位骨化:无骨科手术台直接前路和后路的放射学比较。
Hip Int. 2022 Sep;32(5):604-609. doi: 10.1177/1120700020970793. Epub 2020 Nov 6.
4
NSAIDs for Prophylaxis for Heterotopic Ossification After Total Hip Arthroplasty: A Bayesian Network Meta-analysis.非甾体抗炎药用于全髋关节置换术后异位骨化的预防:一项贝叶斯网络荟萃分析。
Calcif Tissue Int. 2021 Feb;108(2):196-206. doi: 10.1007/s00223-020-00763-7. Epub 2020 Oct 12.
5
Heterotopic Ossification: A Challenging Complication of Total Hip Arthroplasty: Risk Factors, Diagnosis, Prophylaxis, and Treatment.异位骨化:全髋关节置换术的挑战性并发症:危险因素、诊断、预防和治疗。
Biomed Res Int. 2019 Apr 16;2019:3860142. doi: 10.1155/2019/3860142. eCollection 2019.
6
Heterotopic Ossification in Primary Total Hip Arthroplasty Using the Direct Anterior vs Direct Lateral Approach.使用直接前路与直接外侧入路行初次全髋关节置换术中的异位骨化
J Arthroplasty. 2017 Apr;32(4):1323-1327. doi: 10.1016/j.arth.2016.11.030. Epub 2016 Nov 22.
7
Comparative clinical study of the prophylaxis of heterotopic ossifications after total hip arthroplasty using etoricoxib or diclofenac.使用依托考昔或双氯芬酸预防全髋关节置换术后异位骨化的比较临床研究。
Int Orthop. 2016 Apr;40(4):673-80. doi: 10.1007/s00264-015-3077-z. Epub 2016 Jan 4.
8
[Selective COX-2 inhibitor versus nonselective COX-1 and COX-2 inhibitor in the prevention of heterotopic ossification after total hip arthroplasty: a meta-analysis of randomised trials].[选择性环氧化酶-2抑制剂与非选择性环氧化酶-1和环氧化酶-2抑制剂在全髋关节置换术后预防异位骨化中的比较:随机试验的荟萃分析]
Zhongguo Gu Shang. 2014 Jul;27(7):609-14.
9
Effect of a selective COX-2 inhibitor, celecoxib, on heterotopic ossification after total hip arthroplasty: a case-controlled study.选择性环氧化酶-2抑制剂塞来昔布对全髋关节置换术后异位骨化的影响:一项病例对照研究。
Hip Int. 2014 May-Jun;24(3):256-62. doi: 10.5301/hipint.5000109. Epub 2014 Jan 28.
10
Celecoxib and heterotopic bone formation after total hip arthroplasty.塞来昔布与全髋关节置换术后异位骨形成。
J Arthroplasty. 2014 Feb;29(2):390-2. doi: 10.1016/j.arth.2013.06.039. Epub 2013 Aug 6.